This one-year study is designed to investigate the safety and efficacy of TPX-100, a 23-aminoacid chondrogenic peptide, delivered by intra-articular injection in regeneration of knee cartilage in subjects with bilateral osteoarthritis of the knee.
Read more: http://www.clinicaltrials.gov/ct2/show/NCT01925261?cond=%22Arthritis%22&lup_s=08/23/2013&lup_d=30
